Techniques for Outflow Cannula Placement
Fig. 27.1 HeartMate 3 outflow-graft anastomosis on the ascending aorta by adoption of a side clamp (Illustration by Ilaria Bondi’s Peppermint Advertising) Additionally, the outflow may be anastomosed to the…
Intraoperative Right Ventricular Failure Management
LVAD implantation advantages/disadvantages Total CPB MECC Off-pump VA ECMO Hemodilution – priming +++ + − ++ Heparin and anticoagulation level +++ ++ + ++ Inflammatory response syndrome +++ + −…
Preoperative Evaluation of Right Ventricular Function
Fig. 6.1 Pathophysiology of chronic pressure overload-induced right ventricular (RV) dysfunction and irreversible failure in patients with congestive heart failure due to primary impaired left ventricular (LV) function. CO cardiac…
HeartWare® HVAD® System
Fig. 53.1 The HeartWare HVAD system Upon its introduction to the market in 2009, the HVAD system featured several important advantages over the contemporary competition. The device has an integrated…
Gastrointestinal Bleeding
Fig. 47.1 Localization of gastrointestinal bleeding events in patients after LVAD implantation [1] Table 47.1 Lesions identified as source of lower gastrointestinal bleeding in patients after LVAD implantation, modified from…
Mechanical Circulatory Support as Bridge to Recovery
Study (year) Pre-implant diagnosis (number of patients) Follow-up [months] HF recurrence [number (%)] Deaths [number (%)] Post-explant patient survival rates (%) 1 year 3 years 5 years 7 years 10…
Temporary RVAD
Fig. 22.1 RV Failure after LVAD implantation via MS (direct cannulation of RA and PA), explantation via re-sternotomy 22.4.2 Minimally Invasive Placement/Withdrawal Several reports have shown the feasibility of minimally…
The ReinHeart Solution
Fig. 56.1 System components Fig. 56.2 Detailed view of the pump unit 56.1.2 TET System The TET system transmits electrical energy from an external to an internal coil. The subcutaneously…
Acquired von Willebrand Syndrome
Fig. 50.1 Illustration of a von Willebrand factor with the subunits and specific functions (Reproduced with permission from De Meyer et al. [34]) VWF is synthetized in endothelial cells and…
Health-Economic Aspects of MCS Therapy
Implant Cost REMATCH HeartMate II DT Trial p-Value N 54 98 <0.01 Cost ($) 384,260 ± 340,456 193,812 ± 71,027 Median ($) 245,445 186,156 Heart transplant without an LVAD bridge…
